RECENT NEWS
Eli Lilly's weight loss drug almost eliminates the risk of diabetes in overweight adults
Zealand Pharma wants a big partner for its weight loss drug
Zepbound and Mounjaro sales are so hot Eli Lilly increased its full-year sales outlook by $3 billion
Novo Nordisk isn't selling as much Wegovy and Ozempic as expected